ArticleInvestigative ophthalmology & visual science2026
Integrin β3 Promotes Retinal Neovascularization via Endoplasmic Reticulum Stress-Mediated Endothelial Cell Senescence.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Integrin β3 (ITGB3/Itgb3), a transmembrane receptor implicated in cell adhesion and signaling, may regulate cellular senescence. We hypothesized that ITGB3 drives retinal neovascularization (RNV) through endoplasmic reticulum stress (ERS)-mediated endothelial cell (EC) senescence and aimed to delineate the underlying molecular mechanisms. Methods: Retinal vascular EC subpopulations were profiled by single-cell RNA sequencing (scRNA-seq) in an oxygen-induced retinopathy (OIR) model. Immunofluorescence staining further confirmed P21 and Integrin β3 expression. Human retinal microvascular endothelial cells (HRMECs) were transfected with ITGB3 small interfering RNA (siRNA), and cell migration, proliferation, and tube formation were assessed. Cellular senescence was evaluated by SA-β-Gal staining together with enzyme-linked immunosorbent assay and Western blot analysis of senescence markers (p21, PAI-1) and senescence-associated secretory phenotype (SASP) factors. Protein expression of PERK/eIF2α/ATF4 ERS pathway were also examined. Results: ScRNA-seq in the OIR model identified a retinal vascular EC subpopulation associated with cellular senescence and ERS, and Itgb3 expression in ECs was significantly upregulated in the OIR model. Immunofluorescence staining confirmed a marked increase in EC senescence and a specific upregulation of integrin β3 colocalized with ECs in OIR retinas. In vitro, ITGB3 knockdown suppressed HRMEC migration, proliferation, and tube formation. Furthermore, ITGB3 knockdown also attenuated hypoxia-induced activation of the PERK/eIF2α/ATF4 pathway and reduced senescence features, including SA-β-Gal positivity, and the expression of p21, PAI-1, and SASP factors. Conclusions: ITGB3 drives RNV by promoting ERS-mediated EC senescence through activation of the PERK/eIF2α/ATF4 pathway. Targeting this signaling axis may represent a potential therapeutic strategy for RNV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.